Fox Nation: Ibogaine: The Fight of a Lifetime
“Ibogaine: The Fight of a Lifetime” is a Fox Nation news segment highlighting the experiences of Special Operations veterans pursuing psychedelic-assisted therapy to address traumatic brain injury and PTSD.
Fox News: Will Cain Country with Marcus and Amber Capone
Amber and Marcus Capone joined Will Cain on Fox's Will Cain Country to discuss VETS, ibogaine-assisted therapy, and the fight to bring this treatment home to veterans who need it.
- 7.24.2025
- Stanford Research
News-Medical: Ibogaine treatment shows major breakthrough for veterans with brain injuries
Covers the Nature Mental Health paper on magnesium–ibogaine effects on cortical oscillations and neural complexity. It highlights the study as evidence that ibogaine may produce measurable brain-function changes in veterans with TBI.
- 7.23.2025
- News
Advocates want NC legislature to consider rules around psychedelics for PTSD treatment
Advocates in North Carolina are urging lawmakers to support Senate Bill 568, which would create a task force to explore safe, regulated access to psychedelic-assisted therapy for PTSD—especially for veterans. While not legalizing psychedelics, the bill aims to prepare the state for future FDA approval through infrastructure planning and veteran-focused care.
- 7.22.2025
- Stanford Research
U.S. Medicine: Magnesium–Ibogaine Therapy Could Offer Treatment Option for TBI
Summarizes the Nature Mental Health study for a veteran/clinical audience, emphasizing rapid changes in brain activity after treatment. It includes comments from lead author Jennifer Lissemore about why the team studied ibogaine’s effects on brain function.
- 7.16.2025
- News
RFK Jr. and other Trump officials embrace psychedelics after FDA setback
RFK Jr. and former Trump officials are backing psychedelic therapies like MDMA and ibogaine, pushing for FDA approval amid growing bipartisan interest. The article highlights veteran voices, including VETS' Marcus Capone, advocating for access despite safety concerns.
- 7.15.2025
- Stanford Research
Military.com: Veteran Executive Order a Win for Ibogaine, But More Research Needed
Mentions the newer MRI findings showing increased cortical thickness after magnesium–ibogaine treatment. It places the study in the context of veteran advocacy and the need for more rigorous ibogaine research.
- 7.8.2025
- Blog
A New Hope for Healing: Psilocybin Clinical Trial Now Open to Veterans
Thanks to the recent passage of SB5263, Washington State is developing a robust legal framework for Washington residents over the age of 21 to access psilocybin services. With it comes a clinical trial designed specifically for U.S. veterans.
Advocate reacts to Texas governor signing psychedelic research bill into law
An advocate featured by KXAN celebrates Texas’s new legislation as a turning point—allocating $50 million in public funding for ibogaine clinical trials to address PTSD, addiction, and brain injury. She highlights the significance of this support for veterans and first responders.
- 7.2.2025
- News
Why Veterans With PTSD Are Turning to Psychedelics
Veterans are increasingly exploring psychedelic treatments—like ketamine, psilocybin, MDMA, and ibogaine—to heal from PTSD. These therapies tend to be used in guided, clinically-informed settings, with some programs even including spouses for shared healing. Although ibogaine remains illegal in the U.S., many veterans are traveling abroad, driven by promising early results